Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) ...

First, a bit of background on the pain-drug environment ... That's why, following this recent FDA approval, Vertex stock makes a no-brainer biotech stock to buy and hold for the long term.

Vertex Pharmaceuticals (NASDAQ ... according to a Society of Actuaries report. First, a bit of background on the pain-drug environment in the U.S. so far. Options have been limited to over ...

Mistral, the company sometimes considered Europe’s great hope for AI, is releasing several updates to its AI assistant, Le ...

One sickle cell patient told ITV News the new gene therapy being rolled out for use on the NHS means they "finally have something to look towards". | ITV National News ...

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) from In-Line to Outperform. Analyst Price Forecast Suggests 90.46% Upside As ...

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder hope of a cure. Campaigners reacted with joy as health officials approved a ...

Keep your eye on the ball” is a motto for many athletes—and for astronomers trying to find Earth-threatening space rocks ...

Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After ...

"The treatment is an example of true medical innovation and will provide patients with no other options a potential cure for ... It is particularly common in people with an African or Caribbean family ...